Dynamic Electron Paramagnetic Resonance Imaging: Modern Technique for Biodistribution and Pharmacokinetic Imaging
Source abstract
Abstract
The imaging of the biodistribution and pharmacokinetics is critical in understanding the complexity of drug delivery mechanisms, the status of the disease, and the monitoring of the treatment progress. The imaging techniques, such as magnetic resonance imaging, computed tomography, and positron emission tomography, are suitable for clinical applications. However, with regards to the biodistribution and pharmacokinetics, their availability is often limited due to the requirements of ionizing radiation or high magnetic fields, low spatial and temporal resolution (applicable for animals), and high maintenance costs. Electron paramagnetic resonance (EPR) imaging is a technique that allows for the minimal invasive mapping of unique parameters, such as the oxygen concentration, the redox state, the thiol concentration, or the pH level, in vivo . In this work, a high temporal resolution 3D EPR imaging technique was used for assessing the trityl spin probe pharmacokinetics in mice. The results demonstrate the preliminary outcomes in the application of EPR imaging for the comparison of the trityl spin probe pharmacokinetics between that of a healthy mouse and a tumor-bearing mouse. This study will stimulate further investigation into the use of imaging strategies, such as EPR imaging, to analyze pharmacokinetics.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced MRI Techniques and Applications · Electron Spin Resonance Studies · Ultrasound and Hyperthermia Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Faculty of Physics, Adam Mickiewicz University, Poznan 61-614, Poland
Novilet, Poznan 61-371, Poland
Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow 30-387, Poland
Department of Toxicology, Poznan University of Medical Sciences, Poznan 61-631, Poland
Centre for Advanced Technologies, Adam Mickiewicz University, Poznan 61-614, Poland
Funding
Narodowe Centrum Nauki · Narodowe Centrum Badan i Rozwoju
References (54)
Show source-provided references
1. 10.2165/00003088-200241080-0000310.2165/00003088-200241080-00003 ↗
2. 10.1016/bs.apha.2018.02.00210.1016/bs.apha.2018.02.002 ↗
3. 10.1016/j.pharmthera.2018.04.00610.1016/j.pharmthera.2018.04.006 ↗
4. 10.1016/j.acra.2017.10.00410.1016/j.acra.2017.10.004 ↗
5. 10.1002/nbm.336910.1002/nbm.3369 ↗
6. 10.1016/j.diii.2013.10.01010.1016/j.diii.2013.10.010 ↗
7. 10.1007/s10334-005-0022-y10.1007/s10334-005-0022-y ↗
8. 10.1186/1471-2407-12-54410.1186/1471-2407-12-544 ↗
9. 10.7150/thno.532110.7150/thno.5321 ↗
10. 10.1021/nn303955n10.1021/nn303955n ↗
11. 10.1016/j.phrs.2016.11.01410.1016/j.phrs.2016.11.014 ↗
12. 10.1002/cmmi.163010.1002/cmmi.1630 ↗
13. Eaton G. R. · 1991
14. 10.1016/j.jmr.2017.02.01310.1016/j.jmr.2017.02.013 ↗
15. Eaton G. R. · 201010.1007/978-3-211-92948-3 ↗
16. 10.1002/cmr.a.2142610.1002/cmr.a.21426 ↗
17. 10.1016/j.jmr.2004.06.00810.1016/j.jmr.2004.06.008 ↗
18. 10.1016/j.ijrobp.2008.02.02210.1016/j.ijrobp.2008.02.022 ↗
19. 10.1002/mrm.1040810.1002/mrm.10408 ↗
20. 10.1016/j.jmr.2014.03.00110.1016/j.jmr.2014.03.001 ↗
21. 10.1016/j.jmr.2014.09.02210.1016/j.jmr.2014.09.022 ↗
22. 10.3791/5662410.3791/56624 ↗
23. 10.1560/IJC.48.1.2710.1560/IJC.48.1.27 ↗
24. 10.1034/j.1600-0455.2002.430418.x10.1034/j.1600-0455.2002.430418.x ↗
25. 10.1016/j.jmr.2015.08.02710.1016/j.jmr.2015.08.027 ↗
26. 10.1016/j.jmr.2016.12.01510.1016/j.jmr.2016.12.015 ↗
27. 10.1016/j.jmr.2014.02.01510.1016/j.jmr.2014.02.015 ↗
28. 10.1002/cmr.b.2011910.1002/cmr.b.20119 ↗
29. 10.1016/j.jmr.2017.09.00810.1016/j.jmr.2017.09.008 ↗
30. 10.1038/jcbfm.2009.8910.1038/jcbfm.2009.89 ↗
31. 10.1007/s12013-020-00903-810.1007/s12013-020-00903-8 ↗
32. 10.1016/j.freeradbiomed.2020.03.01810.1016/j.freeradbiomed.2020.03.018 ↗
33. 10.1016/j.mri.2012.09.00310.1016/j.mri.2012.09.003 ↗
34. 10.1016/j.acra.2018.08.01610.1016/j.acra.2018.08.016 ↗
35. 10.2463/mrms.mp.2019-002610.2463/mrms.mp.2019-0026 ↗
36. 10.1002/mrm.1073710.1002/mrm.10737 ↗
37. 10.1016/j.mri.2006.10.01110.1016/j.mri.2006.10.011 ↗
38. 10.1002/mrm.2425010.1002/mrm.24250 ↗
39. 10.1002/mrm.1008910.1002/mrm.10089 ↗
40. 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S ↗
41. 10.1002/mrm.191032060610.1002/mrm.1910320606 ↗
42. 10.1002/(SICI)1522-2586(199909)10:3<233::AID-JMRI3>3.0.CO;2-M10.1002/(SICI)1522-2586(199909)10:3<233::AID-JMRI3>3.0.CO;2-M ↗
43. 10.2174/18715201179567752610.2174/187152011795677526 ↗
44. 10.1007/978-1-61737-992-5_2010.1007/978-1-61737-992-5_20 ↗
45. 10.1002/mp.1219610.1002/mp.12196 ↗
46. 10.1016/j.freeradbiomed.2009.06.00710.1016/j.freeradbiomed.2009.06.007 ↗
47. 10.1021/ac300899410.1021/ac3008994 ↗
48. 10.1021/acs.joc.0c0055710.1021/acs.joc.0c00557 ↗
49. 10.1039/C6CS00271D10.1039/C6CS00271D ↗
50. 10.3390/cells809110510.3390/cells8091105 ↗
51. 10.1016/j.redox.2018.01.01510.1016/j.redox.2018.01.015 ↗
52. 10.1016/j.jmr.2012.04.01410.1016/j.jmr.2012.04.014 ↗
53. 10.1016/j.compeleceng.2019.01.01210.1016/j.compeleceng.2019.01.012 ↗
54. 10.2147/IJN.S19477910.2147/IJN.S194779 ↗